H.C. Wainwright Reiterates Buy Rating on Zevra Therapeutics, Inc. (ZVRA)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
| (NASDAQ: ZVRA) | Delayed: 10.39 -0.93 (8.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.32 | 52 Week High | $ | |||
| Open | $11.33 | 52 Week Low | $ | |||
| Day High | $11.33 | P/E | N/A | |||
| Day Low | $10.24 | EPS | $ | |||
| Volume | 1,090,677 | |||||
